Goldstein, L.B., Amarenco, P., LaMonte, M., Gilbert, S., Messig, M., Callahan, A., et al. (2008) Relative Effects of Statin Therapy on Stroke and Cardiovascular Events in Men and Women: Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study. Stroke, 39, 2444-2448.
http://dx.doi.org/10.1161/STROKEAHA.107.513747

has been cited by the following article:

• TITLE: Effects of Pitavastatin on the Intima-Media Thickness of the Carotid Artery in Patients with Ischemic Stroke: The Pitavastatin Efficacy Study on Surrogate Markers and Imaging for Stroke (PESSMIST)

  AUTHORS: Yasushi Shibata

  KEYWORDS: Pitavastatin, Stroke, ECHO, IMT, Hyperlipidemia

  JOURNAL NAME: World Journal of Neuroscience, Vol.4 No.4, July 23, 2014

  ABSTRACT: Pitavastatin is a strong statin that was developed in Japan. The clinical impact of pitavastatin treatment in patients with ischemic stroke has not been reported. We conducted a prospective, open label, clinical case-control study to determine the secondary preventive effects of pitavastatin for patients with cerebral infarction and hyperlipidemia. The pitavastatin group included 20 Japanese patients diagnosed with cerebral infarction and hyperlipidemia without previous statin intake. The control group included 22 patients diagnosed with cerebral infarction without hyperlipidemia. The pitavastatin group of patients received 2 mg of pitavastatin once a day after dinner. The mean age of the patients was 69.3 and 75.5 years for the pitavastatin and control groups, respectively, and the age of the pitavastatin group was significantly younger than that of the control group (P